Case-control study shows MTNR1B gene polymorphisms influence gestational diabetes risk, highlighting interaction with BMI.
To examine the association of MTNR1B gene polymorphisms with the risk of gestational diabetes mellitus (GDM), and further assess whether pre-pregnancy body mass index (BMI) interacted with MTNR1B gene polymorphisms on GDM. This case-control study included 537 GDM cases and 751 controls. Genotyping of the MTNR1B rs1387153, rs10830963, rs4753426, rs3781637 was performed. Pre-pregnancy BMI was classified into three groups: underweight (<18.5 kg/m2), normal weight (18.5-23.9 kg/m2), overweight or obese (BMI ≥24 kg/m2) according to the Chinese standard. Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) between women with and without GDM. After adjusting for potential confounders, each copy of the MTNR1B rs1387153_T allele was associated with a 34% increased risk of GDM (OR: 1.34, 95% CI: 1.13-1.59, p = 0.001), while each copy of the MTNR1B rs10830963_G allele was associated with a 56% higher risk of GDM (OR: 1.56, 95% CI: 1.31-1.85, p < 0.001). A significant interaction between MTNR1B rs1387153 and pre-pregnancy BMI category on the risk of GDM was identified (P for interaction = 0.016 under an additive model and 0.007 under a dominant model). Compared to carriers of rs1387153_CC genotype with pre-pregnancy normal weight, overweight or obese women who carried the genotype of TT or CT had a 3.15-fold increased risk of GDM (OR = 3.15, 95% CI: 2.16-4.59). This study found that MTNR1B rs1387153_T and rs10830963_G were associated with an increased risk of GDM, and pre-pregnancy BMI might influence the effect of MTNR1B rs1387153 polymorphism on the occurrence of GDM.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: